Inventor
YE YING
GB30 patents
⚠️ This page may combine multiple inventors who share the name “YE YING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YE YING
8 patentsUSD719708SDec 16, 2014
Programmable training remote
YE YING24 citations92
USD885692SMay 26, 2020
Cat tree
YE YING9 citations83
USD828009SSep 11, 2018
Umbrella handle
YE YING2 citations72
USD818259SMay 22, 2018
Umbrella handle
YE YING2 citations72
USD791470SJul 11, 2017
Umbrella handle
YE YING2 citations72
USD791469SJul 11, 2017
Umbrella handle
YE YING2 citations72
US9018246B2Apr 28, 2015
Transmucosal administration of taxanes
YE YING1 citations47
US8524469B2Sep 3, 2013
Two-step gram staining method
YE YING0 citations30
CELGENE CORP
5 patentsUS11660302B2May 30, 2023
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
CELGENE CORP1 citations73
US10980812B2Apr 20, 2021
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
CELGENE CORP2 citations73
US10596179B2Mar 24, 2020
3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
CELGENE CORP1 citations73
US10245266B2Apr 2, 2019
3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
CELGENE CORP3 citations73
US11524950B2Dec 13, 2022
Treatment of immune-related and inflammatory diseases
CELGENE CORP0 citations58